Sriram Venkataraman is a Partner at Avista Capital Partners. Mr. Venkataraman joined Avista Capital Partners in 2007. Prior to joining Avista, Mr. Venkataraman was a Vice President in the Healthcare Investment Banking group at Credit Suisse which he joined in 2001. Prior to Credit Suisse, he worked at GE Healthcare (formerly known as GE Medical Systems).
Mr. Venkataraman received a M.S. in Electrical Engineering from the University of Illinois, Urbana-Champaign and an M.B.A. with honors from The Wharton School at the University of Pennsylvania.
Mr. Venkataraman currently serves as a Director of Cosette Pharmaceuticals, eMolecules, National Spine & Pain Centers, Probo Medical, RVL Pharmaceuticals (Nasdaq: RVLP), Solmetex and XIFIN and previously served as a Director of AngioDynamics (NASDAQ: ANGO), Inform Diagnostics, Lantheus Holdings (NASDAQ: LNTH), OptiNose (NASDAQ: OPTN) and Zest Dental Solutions.